UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Improved pharmacokinetics and antihyperlipidemic efficacy of rosuvastatin-loaded nanostructured lipid carriers

Journal of drug targeting, 2017-01, Vol.25 (1), p.58-74

2017

Volltextzugriff (PDF)

Treat-to-Target or High-Intensity Statin in Patients With Coronary Artery Disease: A Randomized Clinical Trial

JAMA : the journal of the American Medical Association, 2023-04, Vol.329 (13), p.1078

2023

Volltextzugriff (PDF)

Virgin Coconut Oil-based Nanostructured Lipid Carrier Improves the Hypolipidemic Effect of Rosuvastatin

International journal of nanomedicine, 2024-01, Vol.19, p.7945-7961

2024

Volltextzugriff (PDF)

Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease

The New England journal of medicine, 2016-05, Vol.374 (21), p.2021-2031

2016

Volltextzugriff (PDF)

Rosuvastatin was not beneficial in reducing arterial stiffness and may be associated with cardiometabolic adverse events in men with HIV

AIDS (London), 2024-09, Vol.38 (11), p.1720-1721

2024

Volltextzugriff (PDF)

Investigating layer-by-layer chitosan-dextran sulfate-coated mesoporous silica as a pH-sensitive drug delivery system

Journal of materials science. Materials in medicine, 2024-06, Vol.35 (1), p.29-12

2024

Volltextzugriff (PDF)

Perioperative Rosuvastatin in Cardiac Surgery

The New England journal of medicine, 2016-05, Vol.374 (18), p.1744-1753

2016

Volltextzugriff (PDF)

Rosuvastatin pharmacokinetics and pharmacogenetics in Caucasian and Asian subjects residing in the United States

European journal of clinical pharmacology, 2015-03, Vol.71 (3), p.329-340

2015

Volltextzugriff (PDF)

Rosuvastatin Improves Endothelial Dysfunction in Diabetes by Normalizing Endoplasmic Reticulum Stress via Calpain-1 Inhibition

Current pharmaceutical design, 2023-01, Vol.29 (32), p.2579-2590

2023

Volltextzugriff (PDF)

Blood-Pressure and Cholesterol Lowering in Persons without Cardiovascular Disease

The New England journal of medicine, 2016-05, Vol.374 (21), p.2032-2043

2016

Volltextzugriff (PDF)

Utilization of Rosuvastatin and Endogenous Biomarkers in Evaluating the Impact of Ritlecitinib on BCRP, OATP1B1, and OAT3 Transporter Activity

Pharmaceutical research, 2023-11, Vol.40 (11), p.2639-2651

2023

Volltextzugriff (PDF)

Coproporphyrins in Plasma and Urine Can Be Appropriate Clinical Biomarkers to Recapitulate Drug-Drug Interactions Mediated by Organic Anion Transporting Polypeptide Inhibition

The Journal of pharmacology and experimental therapeutics, 2016-09, Vol.358 (3), p.397-404

2016

Volltextzugriff (PDF)

Rosuvastatin suppresses TNF-α-induced matrix catabolism, pyroptosis and senescence via the HMGB1/NF-κB signaling pathway in nucleus pulposus cells

Acta biochimica et biophysica Sinica, 2023-05, Vol.55 (5), p.795-808

2023

Volltextzugriff (PDF)

Cholesterol Efflux Capacity, High-Density Lipoprotein Particle Number, and Incident Cardiovascular Events: An Analysis From the JUPITER Trial (Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin)

Circulation (New York, N.Y.), 2017-06, Vol.135 (25), p.2494-2504

2017

Volltextzugriff (PDF)

Development of β-cyclodextrin/polyvinypyrrolidone-co-poly (2-acrylamide-2-methylpropane sulphonic acid) hybrid nanogels as nano-drug delivery carriers to enhance the solubility of Rosuvastatin: An in vitro and in vivo evaluation

PloS one, 2022-01, Vol.17 (1), p.e0263026

2022

Volltextzugriff (PDF)

Rosuvastatin promotes survival of random skin flaps through AMPK-mTOR pathway-induced autophagy

International immunopharmacology, 2023-05, Vol.118, p.110059-110059, Article 110059

2023

Volltextzugriff (PDF)

Cell Membrane-Derived Nanoparticles as Biomimetic Nanotherapeutics to Alleviate Fatty Liver Disease

ACS applied materials & interfaces, 2024-07, Vol.16 (30), p.39117-39128

2024

Volltextzugriff (PDF)

Impact of ABCG2 and SLCO1B1 polymorphisms on pharmacokinetics of rosuvastatin, atorvastatin and simvastatin acid in Caucasian and Asian subjects: a class effect?

European journal of clinical pharmacology, 2015-03, Vol.71 (3), p.341-355

2015

Volltextzugriff (PDF)

Preparation and optimization of tablets containing a self-nano-emulsifying drug delivery system loaded with rosuvastatin

Journal of liposome research, 2018-06, Vol.28 (2), p.149-160

2018

Volltextzugriff (PDF)

Optimization of a drug transporter probe cocktail: potential screening tool for transporter‐mediated drug–drug interactions

British journal of clinical pharmacology, 2018-09, Vol.84 (9), p.1941-1949

2018

Volltextzugriff (PDF)

Carboxylate cross-linked cyclodextrin: A nanoporous scaffold for enhancement of rosuvastatin oral bioavailability

European journal of pharmaceutical sciences, 2018-01, Vol.111, p.1-12

2018

Volltextzugriff (PDF)

UHPLC-MS/MS assay for simultaneous determination of amlodipine, metoprolol, pravastatin, rosuvastatin, atorvastatin with its active metabolites in human plasma, for population-scale drug-drug interactions studies in people living with HIV

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2019-09, Vol.1125, p.121733, Article 121733

2019

Volltextzugriff (PDF)

Effect of Rosuvastatin on Carotid Intima-Media Thickness in Children With Heterozygous Familial Hypercholesterolemia: The CHARON Study (Hypercholesterolemia in Children and Adolescents Taking Rosuvastatin Open Label)

Circulation (New York, N.Y.), 2017-07, Vol.136 (4), p.359-366

2017

Volltextzugriff (PDF)

Acute autoimmune-like hepatitis with atypical anti-mitochondrial antibody after mRNA COVID-19 vaccination: A novel clinical entity?

Journal of autoimmunity, 2021-09, Vol.123, p.102706-102706, Article 102706

2021

Volltextzugriff (PDF)

Influence of OATP1B1 and BCRP polymorphisms on the pharmacokinetics and pharmacodynamics of rosuvastatin in elderly and young Korean subjects

Scientific reports, 2019-12, Vol.9 (1), p.19410-10, Article 19410

2019

Volltextzugriff (PDF)

1 – 25 von 2.859

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(2.640)
Mit Volltextzugriff
(2.273)

Publikationsform

Sprache

11 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(2.469)
Life Sciences & Biomedicine
(2.367)
Humans
(2.253)
Rosuvastatin Calcium
(1.931)
Male
(1.653)
Female
(1.305)
Middle Aged
(1.107)
Hydroxymethylglutaryl-Coa Reductase Inhibitors - Therapeutic Use
(1.075)
Fluorobenzenes - Therapeutic Use
(984)
Sulfonamides - Therapeutic Use
(943)
Pyrimidines - Therapeutic Use
(939)
Rosuvastatin
(912)
Aged
(817)
Cardiovascular System & Cardiology
(810)
Pharmacology & Pharmacy
(771)
Statins
(758)
Cardiac & Cardiovascular Systems
(687)
Animals
(589)
Treatment Outcome
(571)
Adult
(555)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(2.736)
IngentaConnect
(1.376)
EZB Electronic Journals Library
(1.332)
Journals@Ovid Full Text
(1.166)
Elsevier ScienceDirect Journals Complete
(671)
IngentaConnect Journals
(584)
Single Journals
(521)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(470)
Wiley Journals
(377)
Springer journals
(303)
Wiley Online Library
(256)
Taylor & Francis Journals
(205)
Taylor & Francis
(179)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(161)
Taylor & Francis Current Content Access
(153)
Oxford Journals Online Current
(93)
SAGE Publications
(88)
Oxford Journals 2020 Medicine
(71)
Nexis Uni
(57)
EBSCOhost Business Source Ultimate
(55)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(16)
... seit 30 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Improved pharmacokinetics and antihyperlipidemic efficacy of rosuvastatin-loaded nanostructured lipid carriers

Treat-to-Target or High-Intensity Statin in Patients With Coronary Artery Disease: A Randomized Clinical Trial

Virgin Coconut Oil-based Nanostructured Lipid Carrier Improves the Hypolipidemic Effect of Rosuvastatin

Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease

Rosuvastatin was not beneficial in reducing arterial stiffness and may be associated with cardiometabolic adverse events in men with HIV

Investigating layer-by-layer chitosan-dextran sulfate-coated mesoporous silica as a pH-sensitive drug delivery system

Perioperative Rosuvastatin in Cardiac Surgery

Rosuvastatin pharmacokinetics and pharmacogenetics in Caucasian and Asian subjects residing in the United States

Rosuvastatin Improves Endothelial Dysfunction in Diabetes by Normalizing Endoplasmic Reticulum Stress via Calpain-1 Inhibition

Blood-Pressure and Cholesterol Lowering in Persons without Cardiovascular Disease

Utilization of Rosuvastatin and Endogenous Biomarkers in Evaluating the Impact of Ritlecitinib on BCRP, OATP1B1, and OAT3 Transporter Activity

Coproporphyrins in Plasma and Urine Can Be Appropriate Clinical Biomarkers to Recapitulate Drug-Drug Interactions Mediated by Organic Anion Transporting Polypeptide Inhibition

Rosuvastatin suppresses TNF-α-induced matrix catabolism, pyroptosis and senescence via the HMGB1/NF-κB signaling pathway in nucleus pulposus cells

Cholesterol Efflux Capacity, High-Density Lipoprotein Particle Number, and Incident Cardiovascular Events: An Analysis From the JUPITER Trial (Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin)

Development of β-cyclodextrin/polyvinypyrrolidone-co-poly (2-acrylamide-2-methylpropane sulphonic acid) hybrid nanogels as nano-drug delivery carriers to enhance the solubility of Rosuvastatin: An in vitro and in vivo evaluation

Rosuvastatin promotes survival of random skin flaps through AMPK-mTOR pathway-induced autophagy

Cell Membrane-Derived Nanoparticles as Biomimetic Nanotherapeutics to Alleviate Fatty Liver Disease

Impact of ABCG2 and SLCO1B1 polymorphisms on pharmacokinetics of rosuvastatin, atorvastatin and simvastatin acid in Caucasian and Asian subjects: a class effect?

Preparation and optimization of tablets containing a self-nano-emulsifying drug delivery system loaded with rosuvastatin

Optimization of a drug transporter probe cocktail: potential screening tool for transporter‐mediated drug–drug interactions

Carboxylate cross-linked cyclodextrin: A nanoporous scaffold for enhancement of rosuvastatin oral bioavailability

UHPLC-MS/MS assay for simultaneous determination of amlodipine, metoprolol, pravastatin, rosuvastatin, atorvastatin with its active metabolites in human plasma, for population-scale drug-drug interactions studies in people living with HIV

Effect of Rosuvastatin on Carotid Intima-Media Thickness in Children With Heterozygous Familial Hypercholesterolemia: The CHARON Study (Hypercholesterolemia in Children and Adolescents Taking Rosuvastatin Open Label)

Acute autoimmune-like hepatitis with atypical anti-mitochondrial antibody after mRNA COVID-19 vaccination: A novel clinical entity?

Influence of OATP1B1 and BCRP polymorphisms on the pharmacokinetics and pharmacodynamics of rosuvastatin in elderly and young Korean subjects

Suchergebnisse filtern